Cargando…

A nanoparticle therapeutic vaccine targeting HAAH stimulates cellular immunity

Detalles Bibliográficos
Autores principales:	Lebowitz, Michael, Stewart, Solomon, Walker, Susan, Wu, Samindhi, Fuller, Steven, Ghanbari, Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652459/ http://dx.doi.org/10.1186/2051-1426-3-S2-P442

Ejemplares similares

Inhibition of tumor growth in vivo by a nanoparticle-based therapeutic cancer vaccine targeting HAAH
por: Fuller, Steven, et al.
Publicado: (2013)

A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer
por: Fuller, Steven, et al.
Publicado: (2014)

Immunogenicity of a lambda phage-based anti-cancer vaccine targeting HAAH
por: Fuller, Steven, et al.
Publicado: (2013)

Enhanced immunogenicity of a nanoparticle therapeutic cancer vaccine targeting HAAH delivered intradermally using 3M's hollow microstructured transdermal system (hMTS)
por: Fuller, Steven, et al.
Publicado: (2015)

Design, development and production of nano-particle-based anticancer vaccine targeting human aspartyl (asparaginyl) β-hydroxylase (HAAH)
por: Biswas, Biswajit, et al.
Publicado: (2013)

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA
por: Van Gulck, Ellen, et al.
Publicado: (2011)

Cryoablation therapy stimulates the antigen-specific T cell immune responses generated by therapeutic HPV DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2015)

Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
por: Tebas, P, et al.
Publicado: (2012)

Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following SIV challenges of vaccinated monkeys
por: Stephenson, KE, et al.
Publicado: (2012)

Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma
por: Iwagami, Yoshifumi, et al.
Publicado: (2017)

HTLV-1 Tax peptide-carrying polyion complex nanoparticles induce potent cellular immunity in mice
por: Uto, Tomofumi, et al.
Publicado: (2014)

Colony stimulating factors secreted by irradiated autologous tumor cell vaccines inhibit immunity
por: Ravindranathan, Sruthi, et al.
Publicado: (2015)

Robust antibody and cellular responses with an improved DNA vaccine alone
por: Hutnick, N, et al.
Publicado: (2012)

Comparison of cellular and humoral immune responses induced by primary, consensus or mosaic HIV-1 Env DNA vaccines
por: Yan, J, et al.
Publicado: (2012)

In vitro SIV replication kinetics correlate with vaccine induced cellular immune responses and predict post-challenge outcome in immunized rhesus macaques
por: Ochieng, Washingtone, et al.
Publicado: (2006)

Depletion of platelets enhances therapeutic antitumor effects generated by therapeutic DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2013)

Therapeutic efficacy of cancer stem cell vaccine
por: Li, Qiao, et al.
Publicado: (2015)

Persistent immunity after therapeutic vaccination targeting HER2/neu correlated with post-vaccination magnitude of interferon gamma Elispot responses
por: Liao, John B, et al.
Publicado: (2014)

Leukocyte extract reduces HIV replication and modulates cellular factors involved in HIV infection: therapeutic meant
por: Fernandez-Ortega, C, et al.
Publicado: (2010)

A translational in vivo model of trigeminal autonomic cephalalgias – therapeutic characterization with brainstem stimulation
por: Akerman, S, et al.
Publicado: (2013)

Investigation of the therapeutic applications, neuroanatomical targets and emerging technologies in deep brain stimulation surgery
por: Yostos, M, et al.
Publicado: (2015)

In vivo analysis of GenePro, a lentivral therapeutic vaccine
por: Selbovitz, Mariel, et al.
Publicado: (2014)

Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances the efficacy of therapeutic vaccine in cervicovaginal tumor
por: Lee, Sung-Jong, et al.
Publicado: (2015)

P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
por: Gabitzsch, ES, et al.
Publicado: (2009)

Tumor vascular normalization as a strategy to potentiate effectiveness of therapeutic vaccines
por: Farsaci, Benedetto, et al.
Publicado: (2014)

Targeted multi-epitope therapeutic vaccine for the treatment of invasive glioblastoma multiforme
por: Huang, Xiaofang, et al.
Publicado: (2015)

Cellular rhinitis
por: Macchi, Alberto
Publicado: (2015)

Cellular and humoral immune responses against the Plasmodium vivax MSP-1(19) malaria vaccine candidate in individuals living in a Brazilian endemic area in northeastern Amazon
por: Riccio, Evelyn Kety Pratt, et al.
Publicado: (2014)

The inhibitory effect of human umbilical cord mesenchymal stem cells expressing anti-HAAH scFv-sTRAIL fusion protein on glioma
por: Xue, Tian, et al.
Publicado: (2022)

Design and development of a new lentiviral based anti-HIV therapeutic vaccine
por: Rodriguez, M, et al.
Publicado: (2012)

Synergy of therapeutic vaccination against HPV16 oncogenic proteins and standard chemotherapeutics
por: Melief, Cornelis J, et al.
Publicado: (2014)

Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response
por: Antonios, Joseph, et al.
Publicado: (2015)

Therapeutic efficacy of chloroquine and primaquine for Plasmodium vivax malaria treatment in southeast Iran
por: Heidari, Aliehsan, et al.
Publicado: (2012)

P18-09. Persistent virological benefit in SIV-infected macaques upon therapeutic vaccination upon vaccination with DNA vectors
por: Felber, BK, et al.
Publicado: (2009)

Next generation of antiretroviral agents targeting the RNA binding site of the HIV-1 cellular cofactor DDX3: an innovative therapeutic approach
por: Maga, Giovanni, et al.
Publicado: (2012)

Differential induction of IL-1β and tumor necrosis factor by CD40 ligand or cellular contact with stimulated T cells depends on the degree of maturity of human monocytes
por: Burger, D, et al.
Publicado: (2004)

P11-02. In situ analysis by confocal microscopy of the cellular components of mucosal tissues within the framework of preclinical vaccine studies
por: Boggiano, CA, et al.
Publicado: (2009)

Modelling the effects of combining pre-erythrocytic vaccines against Plasmodium falciparum
por: Walker, Andrew, et al.
Publicado: (2014)

NKT cell status and IL-10-dependent therapeutic effect of NKT cell stimulation on collagen-arthritis in DBA/1 mice
por: Bessis, N, et al.
Publicado: (2005)

Spatial stimulation of the electrosensory system of mormyrid electric fish
por: Roberts, Patrick D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_b233n1mlaot0tfkja7jm64sj59